The Center for Global Health Policy’s “Science Speaks” blog highlights “a new report from the United States Government Accountability Office on PEPFAR,” noting it “says improvements in how the program evaluates and communicates its work will be critical to attaining [its] goals” of increasing the number of people on antiretroviral therapy and “‘transitioning’ from providing services and supplies to countries confronting HIV to providing guidance and support.” According to the blog, “The report, [titled] ‘Millions Being Treated, but Better Information Management Needed to Further Improve and Expand Treatment,’ incorporates findings from earlier reports over the last two years on PEPFAR planning, evaluating and reporting, as well as three this year examining PEPFAR drug supply chains, treatment costs and treatment results.” The blog notes, “In the three reports examining components of treatment efforts released in May, the GAO advised that PEPFAR needed to better address weaknesses in recipient country’s management of antiretroviral drugs, gather more comprehensive treatment retention data, and improve the accuracy of its estimates of treatment costs. At the same time, the reports have added up a list of PEPFAR successes” (Barton, 7/9).